Results 41 to 50 of about 73,286 (248)

Molecular association of Candida albicans and vulvovaginal candidiasis: focusing on a solution

open access: yesFrontiers in Cellular and Infection Microbiology, 2023
Candida albicans-mediated vulvovaginal candidiasis (VVC) is a significant challenge in clinical settings, owing to the inefficacy of current antifungals in modulating virulence, development of resistance, and poor penetration into the biofilm matrix ...
Helma David, A. P. Solomon
semanticscholar   +1 more source

Generalidades de la candidiasis vulvovaginal [PDF]

open access: yes, 2023
Vulvovaginal Candidiasis is a disease caused by Candida species, mainly Candida albicans, which can colonize the vaginal mycoflora of healthy women, without causing disease.
González Garro, Ángela   +2 more
core   +2 more sources

Miconazole for the treatment of vulvovaginal candidiasis. In vitro, in vivo and clinical results. Review of the literature

open access: yesJournal of Obstetrics and Gynaecology Research, 2023
At concentrations achieved following systemic administration, the primary effect of imidazoles and triazoles on fungi is inhibition of 14-α-sterol demethylase, a microsomal cytochrome P450 (CYP) enzyme. Imidazoles and triazoles impair the biosynthesis of
P. Regidor   +3 more
semanticscholar   +1 more source

The Role of Probiotics in the Treatment of Vulvovaginal Candidiasis: A Systematic Review and Meta-Analysis

open access: yesEthiopian Journal of Health Sciences, 2023
Background Vulvovaginal candidiasis is one of the most common vaginal infections worldwide. We conducted this systematic review and meta-analysis to determine the effect of probiotics in the treatment of vulvovaginal candidiasis.
Tahere Zahedifard   +2 more
semanticscholar   +1 more source

Clinicomycological study of vulvovaginal candidiasis [PDF]

open access: yesIndian Journal of Sexually Transmitted Diseases and AIDS, 2021
Background: Vaginal candidiasis is one of the most common vaginal infections in women of reproductive age group caused by Candida species of fungi, a normal inhabitant of vagina. Aims: The aim is to study the culture characteristics, species prevalence, and drug sensitivity of ...
Seeniammal, S.   +2 more
openaire   +2 more sources

α-galactosylceramide-stimulated invariant natural killer T-cells play a protective role in murine vulvovaginal candidiasis by Candida albicans.

open access: yesPLoS ONE, 2021
BackgroundVulvovaginal candidiasis is a common superficial candidiasis; however, a host's immunological mechanism against vaginal Candida infection remains unknown.ObjectivesIn this study, we aimed to elucidate the effect of iNKT cell activation on ...
Masahiro Abe   +6 more
doaj   +2 more sources

Vulvovaginal candidiasis: species distribution of Candida and their antifungal susceptibility pattern

open access: yesBMC Women's Health, 2018
Background Vulvovaginal candidiasis is a global issue of concern due to its association with economic costs, sexually transmitted infections, and ascending genital tract infection.
Adane Bitew, Yeshiwork Abebaw
doaj   +1 more source

Study of vulvovaginal candidiasis in symptomatic women of reproductive age group attending tertiary care institute, Haryana province

open access: yesAsian Journal of Medical Sciences, 2021
Background: Abnormal vaginal discharge results from a variety of infectious and noninfectious causes. Vulvovaginal candidiasis (VVC) is caused by the overgrowth of Candida species in the vagina and is characterized by itching, erythema and curd like ...
Gulnar K , Harman Multani
doaj   +1 more source

Candida causes recurrent vulvovaginal candidiasis by forming morphologically disparate biofilms on the human vaginal epithelium

open access: yesBiofilm, 2023
Background Recurrent vulvovaginal candidiasis (RVVC) is a recalcitrant medical condition that affects many women of reproductive age. The importance of biofilm formation by Candida in RVVC has been recently questioned.
Yihong Pan   +15 more
semanticscholar   +1 more source

Vulvovaginal candidiasis

open access: yesBMJ, 2002
Like other syndromes affecting the lower genital tract of women, vulvovaginal candidiasis has been regarded as more of a “nuisance infection” than a topic of serious scientific inquiry. New advances in molecular epidemiology, host mucosal immunology, and antifungal treatment have, however, enlivened investigation into this common condition ...
openaire   +6 more sources

Home - About - Disclaimer - Privacy